Posts tagged TROV


TrovaGene Inc (TROV) Officially Announces Orphan Drug Designation for PCM-075

TrovaGene Inc (NASDAQ:TROV) just made the news official today: As revealed by SmarterAnalyst on Friday (when …

Read more

Here’s Why TrovaGene Inc (TROV) Shares Are Skyrocketing Today

Investors are racing to buy TrovaGene Inc (NASDAQ:TROV) shares after the U.S. Food & Drug Administration (FDA) …

Read more

Analysts Chime In on Three Volatile Biotech Stocks: TrovaGene Inc (TROV), Keryx Biopharmaceuticals (KERX), OHR Pharmaceutical Inc (OHRP)

Healthcare analysts are weighing in on molecular diagnostics firm TrovaGene Inc (NASDAQ:TROV), pharmaceutical company Keryx Biopharmaceuticals (NASDAQ:KERX), …

Read more

Tuesday Morning’s Market Insights: Seadrill Ltd (SDRL), Ambarella Inc (AMBA), Keryx Biopharmaceuticals (KERX), TrovaGene Inc (TROV)

Seadrill Ltd (NYSE:SDRL) is down over 7% due to falling oil prices resulting from a …

Read more

Analysts Chime In on Two Falling Stocks: Stone Energy Corporation (SGY), TrovaGene Inc (TROV)

Stone Energy Corporation Stone Energy Corporation (NYSE:SGY) shares lost almost one-third of their value today …

Read more

Analysts Chime In on Four Healthcare Stocks: Galena Biopharma Inc (GALE), XOMA Corp (XOMA), TrovaGene Inc (TROV), Zogenix, Inc. (ZGNX)

Healthcare analysts came out today with research notes on a handful of biotechnology and medical …

Read more

Company Update (NASDAQ:TROV): TrovaGene Inc Enters into Preferred Provider Agreement with Fortified Provider Network

TrovaGene Inc (NASDAQ:TROV), a developer of cell-free molecular diagnostics, announced today that it has entered into …

Read more

Cantor Weighs In On Two Rising Biotech Stocks: TrovaGene Inc (TROV), Rosetta Genomics Ltd. (USA) (ROSG)

It’s a tale of two biotech firms this afternoon, as shares of TrovaGene Inc (NASDAQ:TROV) are …

Read more

Company Update (NASDAQ:TROV): TrovaGene Inc Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform

TrovaGene Inc (NASDAQ:TROV), a developer of cell-free molecular diagnostics, announced that it has entered into an …

Read more

Analysts Weigh In on Three Biotech Names: TrovaGene Inc (TROV), AEterna Zentaris Inc. (USA) (AEZS), Synthetic Biologics Inc (SYN)

While U.S. stocks traded mostly higher Thursday, as oil recovered slightly from multi-year lows, the …

Read more